Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 47
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Circulating biomarkers of fibrosis in captive gorillas: a pilot study

    Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...

    Do dietary supplements extend lifespan and prevent brain disease?

    Can a cheap, over the counter pill, prevent the onset of ageing-related diseases and extend lifespan? I...

    Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

    Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop...

    Backer Badge Funded